Answers are grounded in this paper and cite their sources.
Ovarian cancer is the third most common gynaecological cancer and has a very high mortality rate. The cornerstone of treatment is complete debulking surgery plus chemotherapy. Even with treatment, 80% of patients have a recurrence. Circulating tumour DNA (ctDNA) has been shown to be useful in the control and follow-up of some tumours. It could be an option to define complete cytoreduction and for the early diagnosis of recurrence.
No takes yet. Share an insight, caveat, or question.
Llueca et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: